Supriya Lifescience Limited (SUPRIYA.BO)
INR 727.3
(-2.28%)
INR 727.3
(-2.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.83 Billion INR | 23.75% |
| 2022 | 1.38 Billion INR | -36.62% |
| 2021 | 2.21 Billion INR | 24.56% |
| 2020 | 1.78 Billion INR | 62.57% |
| 2019 | 1.08 Billion INR | 55.03% |
| 2018 | 724.67 Million INR | 219.0% |
| 2017 | 266.81 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 625.42 Million INR | 12.27% |
| 2024 Q2 | 672.35 Million INR | 3.81% |
| 2023 Q2 | 342.19 Million INR | -27.82% |
| 2023 Q1 | 474.09 Million INR | -18.82% |
| 2023 Q4 | 555.04 Million INR | 24.58% |
| 2023 FY | - INR | 23.75% |
| 2023 Q3 | 445.53 Million INR | 30.2% |
| 2022 Q4 | 584.01 Million INR | 251.66% |
| 2022 Q3 | 166.07 Million INR | -46.72% |
| 2022 Q2 | 311.67 Million INR | -7.25% |
| 2022 Q1 | 336.02 Million INR | -56.95% |
| 2022 FY | - INR | -36.62% |
| 2021 Q1 | 173.92 Million INR | -73.22% |
| 2021 FY | - INR | 24.56% |
| 2021 Q4 | 780.58 Million INR | 78.14% |
| 2021 Q3 | 438.18 Million INR | -54.88% |
| 2021 Q2 | 971.04 Million INR | 458.33% |
| 2020 Q3 | 301.58 Million INR | 0.0% |
| 2020 FY | - INR | 62.57% |
| 2020 Q4 | 649.38 Million INR | 115.33% |
| 2019 FY | - INR | 55.03% |
| 2018 FY | - INR | 219.0% |
| 2017 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | -18032.764% |
| Biocon Limited | 41.52 Billion INR | 95.579% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 19.916% |
| Concord Biotech Limited | 4.65 Billion INR | 60.598% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 40.238% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | -598.853% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | -1245311.188% |
| Lyka Labs Limited | 167.58 Million INR | -995.395% |
| Panacea Biotec Limited | -200.6 Million INR | 1015.135% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 74710.783% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | -425.389% |
| Syngene International Limited | 10.84 Billion INR | 83.076% |
| TAKE Solutions Limited | -1.05 Billion INR | 274.695% |
| Titan Biotech Limited | 360.29 Million INR | -409.515% |
| Transgene Biotek Limited | -4.33 Million INR | 42408.389% |
| Vanta Bioscience Limited | 14.19 Million INR | -12836.093% |